Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gould

Showing results (311-320 of 319) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 319 results.
Nature|May 5, 2016
NMDAR inhibition-independent antidepressant actions of ketamine metabolitesPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Nature Communications|July 7, 2015
The circadian clock rephases during lateral root organ initiation in Arabidopsis thalianaUte Voß, Michael H Wilson, Kim Kenobi, et al.
Molecular Psychiatry|May 13, 2022
Rare variants implicate NMDA receptor signaling and cerebellar gene networks in risk for bipolar disorderNaushaba Hasin, Lace M Riggs, Tatyana Shekhtman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2019
Antidepressant-relevant concentrations of the ketamine metabolite (2<i>R</i>,6<i>R</i>)-hydroxynorketamine do not block NMDA receptor functionEric W Lumsden, Timothy A Troppoli, Scott J Myers, et al.
Molecular Metabolism|June 22, 2024
Autophagic signaling promotes systems-wide remodeling in skeletal muscle upon oncometabolic stress by D2-HGYaqi Gao, Kyoungmin Kim, Heidi Vitrac, et al.
Nature Neuroscience|August 30, 2022
Experimenters' sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factorPolymnia Georgiou, Panos Zanos, Ta-Chung M Mou, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
ATP-dependent citrate lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling of the HeartShijie Liu, Seth T Gammon, Lin Tan, et al.
Clinical Pharmacology and Therapeutics|July 26, 2024
A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy VolunteersShruti M Raja, Jeffrey T Guptill, Michelle Mack, et al.
Gigascience|August 20, 2021
Centering inclusivity in the design of online conferences-An OHBM-Open Science perspectiveElizabeth Levitis, Cassandra D Gould van Praag, Rémi Gau, et al.
Pageof 32

Showing results (311-320 of 319) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 319 results.
Nature|May 5, 2016
NMDAR inhibition-independent antidepressant actions of ketamine metabolitesPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Nature Communications|July 7, 2015
The circadian clock rephases during lateral root organ initiation in Arabidopsis thalianaUte Voß, Michael H Wilson, Kim Kenobi, et al.
Molecular Psychiatry|May 13, 2022
Rare variants implicate NMDA receptor signaling and cerebellar gene networks in risk for bipolar disorderNaushaba Hasin, Lace M Riggs, Tatyana Shekhtman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2019
Antidepressant-relevant concentrations of the ketamine metabolite (2<i>R</i>,6<i>R</i>)-hydroxynorketamine do not block NMDA receptor functionEric W Lumsden, Timothy A Troppoli, Scott J Myers, et al.
Molecular Metabolism|June 22, 2024
Autophagic signaling promotes systems-wide remodeling in skeletal muscle upon oncometabolic stress by D2-HGYaqi Gao, Kyoungmin Kim, Heidi Vitrac, et al.
Nature Neuroscience|August 30, 2022
Experimenters' sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factorPolymnia Georgiou, Panos Zanos, Ta-Chung M Mou, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
ATP-dependent citrate lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling of the HeartShijie Liu, Seth T Gammon, Lin Tan, et al.
Clinical Pharmacology and Therapeutics|July 26, 2024
A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy VolunteersShruti M Raja, Jeffrey T Guptill, Michelle Mack, et al.
Gigascience|August 20, 2021
Centering inclusivity in the design of online conferences-An OHBM-Open Science perspectiveElizabeth Levitis, Cassandra D Gould van Praag, Rémi Gau, et al.
Pageof 32